Itaconate as a Potent Regulator of Neutrophil Responses in Host Defence and Inflammation
Scandinavian Journal of Immunology · 2026-04 · 103 (4)
DOI: 10.1111/sji.70112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 01.04.2026. Verfasst von Chunying Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathogenic Biology, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Succinates, Neutrophils, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China, The science and technology innovation Program of Hunan Province.
Abstract (Originalsprache)
Itaconate, derived from cis‐aconitate decarboxylation by immune‐responsive gene 1 (IRG1; also called cis‐aconitate decarboxylase 1, ACOD1), is an intermediate metabolite of the tricarboxylic acid (TCA) cycle in the mitochondria. The production of itaconate in myeloid cells is rapidly increased to high levels in pathological conditions, such as infection and cancer. It is well known that itaconate plays an essential role in regulating macrophage‐mediated inflammation and immune response through multiple mechanisms, such as regulating signal transduction and protein modification. As the first responders upon infections and injuries, neutrophils contribute to pathogen clearance and inflammation by several mechanisms, such as phagocytosis, producing reactive oxygen species (ROS), and forming neutrophil extracellular traps (NETs). Increasing evidence shows that neutrophils can also produce itaconate, which in turn modulates neutrophil activation, thereby affecting the elimination of pathogens, the resolution of inflammation, and tumour progression. In this review, we summarize the recent advancements in understanding the effects of endogenous itaconate and its derivatives on neutrophil responses, with a focus on the underlying mechanisms and potential therapeutic applications in infectious and inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathogenic Biology, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, China.
- Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, University of South China, Hengyang, China.
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China.
- Department of Pharmacy, The Affiliated Hospital of Yunnan University, Kunming, China.
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
- The science and technology innovation Program of Hunan Province
- Hunan Provincial College Students' innovation and Entrepreneurship Training Program
- Yunnan University Medical Research Foundation
- Yunnan Provincial Department of Education Scientific Research Fund Project
Zitieren
APA
Cheng, C., Cheng, Z., Ye, X., Wang, S., Yan, C., Chen, Y., Li, J., Wu, R., & Lei, A. (2026). Itaconate as a Potent Regulator of Neutrophil Responses in Host Defence and Inflammation. Scandinavian Journal of Immunology, 103(4). https://doi.org/10.1111/sji.70112
Vancouver
Cheng C, Cheng Z, Ye X, Wang S, Yan C, Chen Y, et al. Itaconate as a Potent Regulator of Neutrophil Responses in Host Defence and Inflammation. Scandinavian Journal of Immunology. 2026;103(4). doi:10.1111/sji.70112
BibTeX
@article{Cheng2026,
author = {Cheng, Chunying and Cheng, Zufeng and Ye, Xinran and Wang, Siwei and Yan, Changqing and Chen, Yiran and Li, Jie and Wu, Rundong and Lei, Aihua},
title = {Itaconate as a Potent Regulator of Neutrophil Responses in Host Defence and Inflammation},
journal = {Scandinavian Journal of Immunology},
year = {2026},
volume = {103},
number = {4},
doi = {10.1111/sji.70112}
}
EUVIMED